Hypofractionation and Hydrogel Spacing?


Join our webinar and discover new clinical findings around radiation therapy with SBRT and hydrogel spacing.

“Experience with hydrogel spacer in stereotactic prostate radiotherapy in high-risk localised prostate cancer patients treated with elective nodal irradiation: Results from the SPORT feasibility study.”
Dr. Suneil Jain

"Dose-Escalated Stereotactic Radiotherapy for Prostate Cancer: A Feasibility Study Using a Rectal Spacer and Urethral Sparing”
Dr. Zvi Symon

SpaceOAR Vue

Join our webinar

Advancing Radiation Therapy

SBRT and Hydrogel Spacing

What are the benefits of a hydrogel perirectal spacer?

Thursday, September 30, 2021
Start 17:30pm CEST
(duration 60-90 minutes)


spaceOAR vue

Dr. Suneil Jain
Professor of Clinical Oncology  
Queens University Belfast



Dr. Zvi Symon
Professor Sheba
Medical Center,Tel Hashomer
SpaceOAR Vue
Protect. Contour. Irradiate.

The new SpaceOAR Vue™ Hydrogel is an absorbable hydrogel spacer designed to protect your patient’s rectum by minimising negative radiation side effects during prostate cancer treatment. It is safe, easily injectable and visible on CT scan, intended to improve contouring accuracy and to potentially optimise treatment planning. See how it works and watch recorded webinars from international experts.

What is your area of expertise?
spaceOAR Vue
Discover how SpaceOAR Vue Hydrogel may help you provide better care for your patients, from treatment to recovery and beyond.
spaceOAR Vue
Discover how SpaceOAR Vue Hydrogel could help you protect your patients’ quality of life through potentially more efficient and effective radiotherapy treatment.
Patient stories
Patients treated with SpaceOAR™ Hydrogel report a higher quality of life after prostate cancer radiation 
treatment and experience minimal adverse side effects.1
Discover more stories


1. Mariados N, Sylvester J, Shah D, et al. Hydrogel spacer prospective multicenter randomized controlled pivotal trial: Dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):971-7.

* A Randomised Feasibility Study Evaluating Stereotactic Prostate RadioTherapy in High-Risk Localised Prostate Cancer With or Without Elective Nodal Irradiation SPORTS High-Risk Study. Sponsored by Boston Scientific.

** Dose-escalated prostate stereotactic radiotherapy: A feasibility study using rectal spacer and urethra sparing. Lewin Ron, Bar-Orian Idan, Honig Nir, Tsvang Lev, Ben-Ayun Maoz, Weiss Ilana, Simon Zvi


Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. Please check availability with your local sales representative or customer service.

SpaceOAR and SpaceOAR Vue Hydrogels are intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of SpaceOAR and SpaceOAR Vue Hydrogels to reduce the radiation dose delivered to the anterior rectum. As with any medical treatment, there are some risks involved with the use of SpaceOAR and SpaceOAR Vue Hydrogels. Potential complications associated with SpaceOAR and SpaceOAR Vue Hydrogels include, but are not limited to: pain associated with SpaceOAR and SpaceOAR Vue Hydrogels injection; pain or discomfort associated with SpaceOAR and SpaceOAR Vue Hydrogels; needle penetration of the bladder, prostate, rectal wall, rectum or urethra; injection of SpaceOAR and SpaceOAR Vue Hydrogels into the bladder, prostate, rectal wall, rectum or urethra; local inflammatory reactions; infection; injection of air, fluid or SpaceOAR and SpaceOAR Vue Hydrogels intravascularly; urinary retention; rectal mucosal damage, ulcers, necrosis; bleeding; and rectal urgency.

All images are the property of Boston Scientific. All trademarks are the property of their respective owners.